The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Konverge 20mg/5mg film-coated tablets



IMED Healthcare Ltd.PPA1463/104/001

Main Information

Trade NameKonverge 20mg/5mg film-coated tablets
Active SubstancesAmlodipine
Olmesartan medoxomil
Dosage FormFilm-coated tablet
Licence HolderIMED Healthcare Ltd.
Licence NumberPPA1463/104/001

Group Information

ATC CodeC09DB Angiotensin II antagonists and calcium channel blockers
C09DB02 olmesartan medoxomil and amlodipine

Status

License statusWithdrawn
Withdrawn Date26/08/2021
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusUnknown

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0046-092-003
Interchangeable List DocumentPDF of Interchangeable List
« Back